Related Experiment Video
Updated: Feb 5, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Sleep-Disordered Breathing is Associated With Increased Mortality in Hospitalized Infants With Congenital Heart
Daniel Combs1,2,3, Grant Skrepnek4, Michael D Seckeler5
1Department of Pediatrics, Division of Pulmonary and Sleep Medicine, University of Arizona, Tucson, Arizona.
Insights
Sleep-disordered breathing (SDB) in infants with congenital heart disease (CHD) is linked to higher mortality, longer hospital stays, and increased costs. Central sleep apnea showed the most significant adverse outcomes in this vulnerable population.
Area of Science:
- Pediatric Cardiology
- Sleep Medicine
- Healthcare Outcomes Research
Background:
- Sleep-disordered breathing (SDB) is known to have adverse cardiovascular effects in adults.
- The prevalence and impact of SDB in infants with congenital heart disease (CHD) remain understudied.
- Existing research highlights SDB's association with increased mortality in adults with cardiac conditions.
Purpose of the Study:
- To investigate the clinical and economic outcomes associated with SDB in hospitalized infants diagnosed with CHD in the United States.
- To determine if SDB confers a similar increased mortality risk in infants with CHD as observed in adults.
- To evaluate the impact of SDB on length of stay and total charges for infants with CHD.
Main Methods:
- A retrospective, cross-sectional study utilizing the Kids' Inpatient Database (1997-2012).
- Inclusion criteria: infants (<1 year) with diagnosed CHD. Exclusions: prematurity apnea, cardiac surgery, invasive ventilation.
- Generalized linear models were employed to analyze mortality, length of stay, and total charges, controlling for covariates.
Main Results:
- Among 461,778 infant CHD cases, 4,839 (1.0%) had SDB (14% obstructive, 4% central, 82% unspecified).
- Central sleep apnea was significantly associated with increased inpatient mortality (OR 4.3), longer length of stay (+92%), and higher total charges (+112%) (P < .05).
- Obstructive and unspecified SDB were also linked to longer stays and higher charges compared to infants without SDB (P < .001).
Conclusions:
- Sleep-disordered breathing, especially central sleep apnea, is independently associated with adverse clinical and economic outcomes in hospitalized infants with CHD.
- These findings underscore the importance of recognizing and managing SDB in this high-risk infant population.
- Further research is warranted to explore the potential benefits of SDB treatment in mitigating adverse outcomes for infants with CHD.
Study Objectives:
Sleep-disordered breathing (SDB) has adverse cardiovascular effects in children and adults. In adults with cardiac disease, SDB is highly prevalent and confers increased mortality risk. It is unknown if SDB confers a similar risk in infants with congenital heart disease (CHD). We evaluated clinical and economic outcomes associated with SDB among inpatient infants with CHD in the United States from 1997-2012.
Methods:
This retrospective, cross-sectional study used discharge data from the Kids' Inpatient Database. Inclusion criteria included diagnosed CHD and age younger than 1 year. Exclusion criteria included apnea of prematurity, cardiac surgery during admission, and invasive mechanical ventilation. Generalized linear models were used to assess outcomes of mortality, length of stay, and total charges after controlling for SDB, clinical characteristics, hospital characteristics, and economic factors.
Results:
Across 461,778 inpatient infant cases of CHD from 1997-2012, 4,839 involved SDB (14% obstructive, 4% central, 82% not specified). Multivariable analyses show that central sleep apnea was independently associated with increased risk of inpatient mortality (odds ratio 4.3), 92% longer inpatient stay, and 112% higher total charges when compared to infants with CHD without comorbid SDB (P < .05). Obstructive and unspecified SDB were associated with longer adjusted lengths of stay (56% and 18%, respectively) and higher charges (48% and 21%, respectively) relative to infants with CHD without comorbid SDB (P < .001).
Conclusions:
SDB, particularly central sleep apnea, was independently associated with worse outcomes in hospitalized infants with CHD. Further research on whether treatment of SDB in infants with CHD can abrogate adverse patient outcomes is needed.
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Hospitals-II
Nurses that work in...
Breathing
Hospitals-I
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

